Epizyme gets FDA priority review for TAZVERIK in follicular lymphoma
Epizyme has been granted priority review by the US Food and Drug Administration (FDA) for the use of…
ALX Oncology raises $105m to advance clinical development of ALX148
ALX Oncology, a clinical-stage immuno-oncology company based in California, has raised $105 million in a Series C equity…
ImmunogenX enrolls patients for Solutions for Celiac trial of Latiglutenase
ImmunogenX, a subsidiary of Immunogenics, has started enrollment of patients for a phase 2b clinical trial to evaluate…
Pinpoint Therapeutics secures funds for developing autophagy inhibitors for cancer
Pinpoint Therapeutics, a US biopharma company focused on developing autophagy inhibitors for cancer treatment, has secured $1 million…
Antios Therapeutics begins phase 1 trial for ATI-2173, a chronic hepatitis B candidate
US biopharma company Antios Therapeutics has initiated its first-in-human phase 1 clinical trial for ATI-2173, a liver-targeted, orally-administered,…
Australian clinical diagnostics company SpeeDx raises $15m in Series B round
SpeeDx, an Australian clinical diagnostics company, to support improved patient outcomes, has secured $15 million in a Series…
PCI acquires Canadian pharma packaging company Bellwyck Pharma Services
PCI Pharma Services, a pharma supply chain solutions provider, has acquired Canada-based pharma packaging company Bellwyck Pharma Services…
Catalent Pharma Solutions acquires cell and gene therapy CDMO MaSTherCell
Drug manufacturer Catalent Pharma Solutions has wrapped up its previously announced $315 million acquisition of MaSTherCell Global, a…
Olympus secures FDA clearance for TJF-Q190V duodenoscope
Olympus Medical Systems Group has secured clearance from the US Food and Drug Administration (FDA) for its TJF-Q190V…
CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the…